Hyderabad, December 06, 2022:
Hyderabad-based MapMyGenome has launched its pharmacogenomics solution MedicaMap.
MedicaMap is MapMyGenome's cutting-edge pharmacogenomic solution that analyses an individual's response to medicines, based on genetic makeup. This pharmacogenomic solution analyses 165+ US-FDA-approved drugs across 12 different specialties such as psychiatry, oncology, cardiology, diabetology, and many more.
MapMyGenome CEO Anu Acharya said, "MedicaMap is a one of a kind phamacogenomic product which provides you detailed analysis of your body's response to medicine based on your genetic makeup.
It is affordable, non-invasive, once-in-a lifetime. You can do it from your own home. We have introduced it at Rs 6499 for over 165 drugs, which is probably the lowest price."
